Bronte Capital Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-906,157
| Closed | -$1.98M | – | 29 |
|
|
2024
Q1 | $1.98M | Sell |
906,157
-13,754
| -1% | -$30K | 0.16% | 29 |
|
|
2023
Q4 | $1.43M | Sell |
919,911
-5,334
| -0.6% | -$8.27K | 0.13% | 29 |
|
|
2023
Q3 | $1.19M | Hold |
925,245
| – | – | 0.12% | 28 |
|
|
2023
Q2 | $1.59M | Buy |
925,245
+7,491
| +0.8% | +$12.9K | 0.15% | 31 |
|
|
2023
Q1 | $1.39M | Buy |
+917,754
| New | +$1.39M | 0.16% | 29 |
|